← FDA DRUG APPROVALS

FDA NDA · NDA214916

KORSUVA

difelikefalin

Sponsor: VIFOR INTL

APPLICATION
NDA214916
TYPE
NDA
ORIGINAL APPROVAL
2021-08-23
LATEST ACTION
2025-03-25
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

KORSUVA · ReferencePrescription
DIFELIKEFALIN ACETATE EQ 0.065MG BASE/1.3ML (EQ 0.05MG BASE/ML) · SOLUTION · INTRAVENOUS

Approval history

2025-03-25Manufacturing (CMC) · Supplement 2 · standardLabelAP
2021-08-23Type 1 - New Molecular Entity · Original · priorityLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →